WO2025017453 - A PROCESS FOR THE PREPARATION OF SOLID FORMS OF SUVOREXANT
National phase entry is expected:
Publication Number
WO/2025/017453
Publication Date
23.01.2025
International Application No.
PCT/IB2024/056831
International Filing Date
13.07.2024
Title **
[English]
A PROCESS FOR THE PREPARATION OF SOLID FORMS OF SUVOREXANT
[French]
PROCÉDÉ DE PRÉPARATION DE FORMES SOLIDES DE SUVOREXANT
Applicants **
BIOPHORE INDIA PHARMACEUTICALS PVT. LTD
Inventors
PULLAGURLA, Manik Reddy
KOTHAKONDA, Kiran Kumar
ARUTLA, Srinivas
PITTA, Bhaskar Reddy
BOGE, Rajesham
RANGISETTY, Jagadeesh Babu
Priority Data
202341047499
14.07.2023
IN
202341069321
14.10.2023
IN
202441026499
30.03.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2421 | |
| EPO | Filing, Examination, Granting | 14461 | |
| Japan | Filing, Examination, Granting | 2337 | |
| South Korea | Filing, Examination, Granting | 2497 | |
| USA | Filing, Examination, Granting | 8340 |
Total:
30,056
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a process for the preparation of solid forms of Suvorexant (1) with at least one pharmaceutically acceptable excipient It further relates to a process for the preparation of amorphous form of Suvorexant (1). The present invention is further directed to a pharmaceutical composition comprising a solid dispersion of suvorexant with at least one pharmaceutically acceptable excipient and process for the preparation thereof.[French]
La présente invention concerne un procédé de préparation de formes solides de suvorexant (1) avec au moins un excipient pharmaceutiquement acceptable. L'invention concerne par ailleurs un procédé de préparation d'une forme amorphe de suvorexant (1). La présente invention concerne en outre une composition pharmaceutique comprenant une dispersion solide de suvorexant avec au moins un excipient pharmaceutiquement acceptable et son procédé de préparation.